Sex Differences in Lopinavir Concentrations and Occurrence of Marked QTc Prolongation Episodes in Patients with COVID-19
Détails
Etat: Public
Version: Final published version
Licence: Non spécifiée
ID Serval
serval:BIB_087C444907D1
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Compte-rendu: analyse d'une oeuvre publiée.
Collection
Publications
Institution
Titre
Sex Differences in Lopinavir Concentrations and Occurrence of Marked QTc Prolongation Episodes in Patients with COVID-19
Périodique
Drug Saf
ISSN
1179-1942 (Electronic)
0114-5916 (Print)
0114-5916 (Print)
ISSN-L
0114-5916
Statut éditorial
Publié
Date de publication
02/2021
Peer-reviewed
Oui
Volume
44
Numéro
2
Pages
255-257
Langue
anglais
Notes
Marzolini, Catia
Stader, Felix
Leuppi-Taegtmeyer, Anne
Stoeckle, Marcel
Battegay, Manuel
Sendi, Parham
eng
Comment
Letter
New Zealand
Drug Saf. 2021 Feb;44(2):255-257. doi: 10.1007/s40264-020-01025-z. Epub 2020 Nov 27.
Stader, Felix
Leuppi-Taegtmeyer, Anne
Stoeckle, Marcel
Battegay, Manuel
Sendi, Parham
eng
Comment
Letter
New Zealand
Drug Saf. 2021 Feb;44(2):255-257. doi: 10.1007/s40264-020-01025-z. Epub 2020 Nov 27.
Mots-clé
*Drug-Related Side Effects and Adverse Reactions, Female, Humans, *Long QT Syndrome/chemically induced/diagnosis, Lopinavir/adverse effects, Male, *Pharmaceutical Preparations, SARS-CoV-2, Sex Characteristics, *COVID-19 Drug Treatment
Pubmed
Création de la notice
25/08/2023 6:17
Dernière modification de la notice
27/08/2023 7:08
Données d'usage
